Clinical and laboratory differences between pediatric hospitalized patients with sickle cell disease infected or not by SARS-CoV-2.

Gabriella Mafra Elia Tulio Konstantyner Rafaela Pilotto Nais Andreia Regina Augusto Dos Santos Andrea Angel Josefina Aparecida Pellegrini Braga

Published in: Revista paulista de pediatria : orgao oficial da Sociedade de Pediatria de Sao Paulo (2023)

Pediatric hospitalized patients with sickle cell disease infected by SARS-CoV-2 had more comorbidities and had a decrease in eosinophil count between hospital admission and the last medical appointment.

Keyphrases

sars cov
respiratory syndrome coronavirus
healthcare
emergency department
adverse drug
young adults